| ID Source | ID |
|---|---|
| PubMed CID | 15891 |
| SCHEMBL ID | 3302 |
| MeSH ID | M0101539 |
| Synonym |
|---|
| ec 217-547-8 |
| unii-6tnd0d6d3y |
| phenyl chloroformate [un2746] [poison] |
| 6tnd0d6d3y , |
| tl 398 |
| einecs 217-547-8 |
| un2746 |
| fenylester kyseliny chlormravenci [czech] |
| nsc 210946 |
| brn 0606778 |
| formic acid, chloro-, phenyl ester |
| nsc-210946 |
| 1885-14-9 |
| fenylester kyseliny chlormravenci |
| phenyl chloroformate |
| phenoxycarbonyl chloride |
| carbonochloridic acid, phenyl ester |
| chloroformic acid phenyl ester |
| phenyl chlorocarbonate |
| wln: gvor |
| nsc210946 |
| phenyl chloroformate, 99% |
| phenyl chloroformate, 97% |
| phenyl carbonochloridate |
| FT-0651614 |
| AKOS000120952 |
| phenylchloroformate |
| BBL011406 |
| carbonochloridic acid phenyl ester |
| STL146510 |
| AM20050150 |
| SCHEMBL3302 |
| phenylchloroformic acid |
| phenyloxycarbonyl chloride |
| phenyl chloroformat |
| phenyl chloroform ate |
| clco2ph |
| phococl |
| chloroformic acid-phenyl ester |
| phenoxycarbonylchloride |
| phenyl choroformate |
| phenyl chioroformate |
| phenychloroformate |
| phenylchlorformate |
| phenyl chloridocarbonate |
| phenylcarbonochloridate |
| un 2746 |
| phenyl chloridocarbonate # |
| tox21_303763 |
| NCGC00357059-01 |
| dtxcid7024403 |
| dtxsid9044403 , |
| cas-1885-14-9 |
| J-523932 |
| F0001-0676 |
| mfcd00000637 |
| phenyl chloroformate, purum, >=98.0% (gc) |
| J-012146 |
| BCP14449 |
| Q16760605 |
| BP-31146 |
| EN300-20701 |
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 54.4827 | 0.0015 | 30.6073 | 15,848.9004 | AID1224841; AID1259401 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (52.02) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||